Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Atreca Inc Cl A (BCEL)

Atreca Inc Cl A (BCEL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 248,297
  • Shares Outstanding, K 36,894
  • Annual Sales, $ 0 K
  • Annual Income, $ -86,330 K
  • 60-Month Beta 0.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.14
Trade BCEL with:

Options Overview Details

View History
  • Implied Volatility 107.08%
  • Historical Volatility 41.90%
  • IV Percentile 43%
  • IV Rank 24.46%
  • IV High 241.12% on 07/14/21
  • IV Low 63.68% on 10/20/20
  • Put/Call Vol Ratio 0.17
  • Today's Volume 42
  • Volume Avg (30-Day) 223
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 1,357
  • Open Int (30-Day) 3,135

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/21
See More
  • Average Estimate -0.75
  • Number of Estimates 7
  • High Estimate -0.71
  • Low Estimate -0.78
  • Prior Year -0.66
  • Growth Rate Est. (year over year) -13.64%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.51 +21.05%
on 08/25/21
6.75 -1.19%
on 09/22/21
+1.13 (+20.40%)
since 08/20/21
3-Month
4.80 +38.96%
on 07/30/21
9.77 -31.73%
on 07/12/21
-1.80 (-21.25%)
since 06/22/21
52-Week
4.80 +38.96%
on 07/30/21
20.29 -67.13%
on 02/12/21
-6.78 (-50.41%)
since 09/22/20

Most Recent Stories

More News
Atreca Reports Second Quarter 2021 Financial Results and Recent Corporate Developments

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active...

BCEL : 6.67 (-0.89%)
Atreca to Present at Upcoming Virtual Investor Conferences

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active...

BCEL : 6.67 (-0.89%)
Atreca Presents Initial Clinical Data from Phase 1b Trial of ATRC-101 in Select Advanced Solid Tumors

Completed dose escalation portion of Phase 1b trial; ATRC-101 was well-tolerated with no dose-limiting toxicities observed

BCEL : 6.67 (-0.89%)
Atreca to Host Webcast Presentation of Initial Clinical Data from Phase 1b Trial of ATRC-101

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active...

BCEL : 6.67 (-0.89%)
Atreca Announces Appointment of Dr. Stacey Ma and Stephen R. Brady to its Board of Directors

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active...

BCEL : 6.67 (-0.89%)
Atreca to Present at Upcoming Virtual Investor Conferences

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response,...

BCEL : 6.67 (-0.89%)
Atreca Reports First Quarter 2021 Financial Results and Recent Corporate Developments

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active...

BCEL : 6.67 (-0.89%)
Atreca to Present at Upcoming Virtual Investor Conferences

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune response,...

BCEL : 6.67 (-0.89%)
Atreca Announces Poster Presentation at the Virtual American Association for Cancer Research (AACR) Annual Meeting

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active...

BCEL : 6.67 (-0.89%)
Atreca Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Corporate Developments

Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active...

BCEL : 6.67 (-0.89%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Atreca is a biopharmaceutical company utilizing its differentiated platform to discover and develop novel antibody-based immunotherapeutics to treat a range of solid tumor types. While more traditional oncology drug discovery approaches attempt to generate antibodies against known targets, Atreca's approach...

See More

Key Turning Points

3rd Resistance Point 7.02
2nd Resistance Point 6.88
1st Resistance Point 6.78
Last Price 6.67
1st Support Level 6.54
2nd Support Level 6.40
3rd Support Level 6.30

See More

52-Week High 20.29
Fibonacci 61.8% 14.37
Fibonacci 50% 12.55
Fibonacci 38.2% 10.72
Last Price 6.67
52-Week Low 4.80

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar